当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 现金流量表

益盛药业

(002566)

  

流通市值:14.32亿  总市值:20.42亿
流通股本:2.32亿   总股本:3.31亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金459,554,670.58374,158,352.6201,484,029.37717,941,855.94
  收到的税费返还503,829.99503,829.99232,004.03703,253.65
  收到其他与经营活动有关的现金21,678,447.9614,535,858.1710,379,069.7419,797,954.96
  经营活动现金流入小计481,736,948.53389,198,040.76212,095,103.14738,443,064.55
  购买商品、接受劳务支付的现金67,645,891.5548,669,582.422,237,359.4486,056,636.34
  支付给职工以及为职工支付的现金88,736,607.861,547,901.2433,852,466.16127,575,337.36
  支付的各项税费67,611,631.0250,083,883.2723,768,308.1790,474,137.61
  支付其他与经营活动有关的现金227,021,008.94188,823,315.42100,634,563.49335,597,339.39
  经营活动现金流出小计451,015,139.31349,124,682.33180,492,697.26639,703,450.7
  经营活动产生的现金流量净额30,721,809.2240,073,358.4331,602,405.8898,739,613.85
二、投资活动产生的现金流量:
  收回投资收到的现金501,720,000451,720,000160,000,000450,000,000
  取得投资收益收到的现金13,431,207.9711,775,005.872,999,228.6913,015,093.77
  处置固定资产、无形资产和其他长期资产收回的现金净额---275,210.14
  投资活动现金流入小计515,151,207.97463,495,005.87162,999,228.69463,290,303.91
  购建固定资产、无形资产和其他长期资产支付的现金2,002,163.11,707,373.811,195,665.2213,640,591.64
  投资支付的现金520,000,000480,000,00050,000,000501,762,177.52
  支付其他与投资活动有关的现金---1,303,300
  投资活动现金流出小计522,002,163.1481,707,373.8151,195,665.22516,706,069.16
  投资活动产生的现金流量净额-6,850,955.13-18,212,367.94111,803,563.47-53,415,765.25
三、筹资活动产生的现金流量:
  取得借款收到的现金330,000,000330,000,000210,000,000333,000,000
  收到其他与筹资活动有关的现金17,400,00017,400,0007,400,00020,000,000
  筹资活动现金流入小计347,400,000347,400,000217,400,000353,000,000
  偿还债务支付的现金290,100,000290,100,000170,000,000355,000,000
  分配股利、利润或偿付利息支付的现金35,063,721.7132,203,549.792,842,505.8445,607,753.11
  支付其他与筹资活动有关的现金24,524,820.2624,350,984.3417,151,772.65,641,791.15
  筹资活动现金流出小计349,688,541.97346,654,534.13189,994,278.44406,249,544.26
  筹资活动产生的现金流量净额-2,288,541.97745,465.8727,405,721.56-53,249,544.26
四、汇率变动对现金及现金等价物的影响-0.11-0.08-0.04164.38
五、现金及现金等价物净增加额21,582,312.0122,606,456.28170,811,690.87-7,925,531.28
  加:期初现金及现金等价物余额63,554,309.9163,554,309.9163,554,309.9171,479,841.19
  期末现金及现金等价物余额85,136,621.9286,160,766.19234,366,000.7863,554,309.91
补充资料:
  净利润-27,828,590.67-28,930,178.16
  资产减值准备-4,143,857.62-5,174,518.61
  固定资产和投资性房地产折旧-17,882,180.51-35,820,571.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-17,882,180.51-35,820,571.82
  无形资产摊销-1,341,658.43-2,683,316.86
  长期待摊费用摊销-339,348.69-684,267.45
  处置固定资产、无形资产和其他长期资产的损失----400,967.64
  固定资产报废损失-166,922.87-303,922.18
  公允价值变动损失--2,542,771.84-3,824,213.82
  财务费用-5,819,260.38-12,621,806.38
  投资损失--11,959,776.69--13,350,997.91
  递延所得税--1,116,852.75--3,130,766.38
  其中:递延所得税资产减少--1,132,715.56--2,700,146.98
    递延所得税负债增加-15,862.81--430,619.4
  存货的减少-8,769,720.43-43,027,579.96
  经营性应收项目的减少--10,695,933.25--29,646,137.38
  经营性应付项目的增加--1,910,788.62-8,005,071.06
  现金的期末余额-86,160,766.19-63,554,309.91
  减:现金的期初余额-63,554,309.91-71,479,841.19
  现金及现金等价物的净增加额-22,606,456.28--7,925,531.28
公告日期2026-10-272026-08-252026-04-252026-04-17
审计意见(境内)标准无保留意见
TOP↑